Literature DB >> 7368045

Isolation and characterization of 5-fluorouracil-resistant mutants of Chinese hamster ovary cells deficient in the activities of orotate phosphoribosyltransferase and orotidine 5'-monophosphate decarboxylase.

D Patterson.   

Abstract

A rapid, simple method for isolation of large numbers of Chinese hamster ovary cell (CHO-K1) mutants deficient in the final two enzymes of UMP biosynthesis, orotate phosphoribosyltransferase (EC 2.4.2.10), and OMP decarboxylase (EC 4.1.1.23) is described. The method takes advantage of the fact that CHO-K1 cells require orotate phosphoribosyltransferase to activate the pyrimidine analog 5-fluorouracil to its active form; hence, mutants lacking thhe relevance of these observations to the metabolism of this cancer chemotheraputic agent, to the study of the structure of the protein(s) involved in catalyzing the last two steps of UMP biosynthesis, to the study of the structure of the gene(s) coding for this protein, and to analysis of the human genetic disease orotic aciduria is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7368045     DOI: 10.1007/bf01538699

Source DB:  PubMed          Journal:  Somatic Cell Genet        ISSN: 0098-0366


  4 in total

1.  Mapping of the gene encoding the multifunctional protein carrying out the first three steps of pyrimidine biosynthesis to human chromosome 2.

Authors:  K C Chen; D B Vannais; C Jones; D Patterson; J N Davidson
Journal:  Hum Genet       Date:  1989-04       Impact factor: 4.132

2.  Molecular cloning and nucleotide sequence for the complete coding region of human UMP synthase.

Authors:  D P Suttle; B Y Bugg; J K Winkler; J J Kanalas
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

3.  Demonstration, by somatic cell genetics, of coordinate regulation of genes for two enzymes of purine synthesis assigned to human chromosome 21.

Authors:  D Patterson; S Graw; C Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

4.  Decreased host toxicity in vivo during chronic treatment with 5-flourouracil.

Authors:  J W Darnowski; R C Sawyer; R L Stolfi; D S Martin; C A Lau-Cam
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.